Amyloid: Morphology and toxicity

Clinical Chemistry and Laboratory Medicine

Volumn 40, Issue 12, 2002, Pages 1266-1270

  Olofsson, Anders ^a   Östman, Johan ^a   Lundgren, Erik ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloid; Apoptosis; Transthyretin

Indexed keywords

AMYLOID; MUTANT PROTEIN; PREALBUMIN; TETRAMER;

APOPTOSIS; ATOMIC FORCE MICROSCOPY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; ENTROPY; HUMAN; HUMAN CELL; MOLECULAR STABILITY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STRUCTURE; REVIEW; TEMPERATURE DEPENDENCE;

AMYLOID; APOPTOSIS; HELA CELLS; HUMANS; MICROSCOPY, ATOMIC FORCE; MUTATION; PREALBUMIN; PROTEIN BINDING; PROTEIN FOLDING;

EID: 0036910631     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2002.219     Document Type: Review

References (28)

1. Wood SJ, Wetzel R, Martin JD, Hurle MR. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4. Biochemistry 1995; 34:724-30.
2. Kayed R, Bernhagen J, Greenfield N, Sweimeh K, Brunner H, Voelter W, et al. Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J Mol Biol 1999; 287:781-96.
3. Kirschner DA, Abraham C, Selkoe DJ. X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation [published erratum appears in Proc Natl Acad Sci USA 1986; 83:2776]. Proc Natl Acad Sci USA 1986; 83:503-7.
4. McCutchen SL, Colon W, Kelly JW. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 1993; 32:12119-27.
5. Quintas A, Vaz DC, Cardoso I, Saraiva MJ, Brito RM. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J Biol Chem 2001; 276:27207-13.
6. Jiang X, Smith CS, Petrassi HM, Hammarstrom P, White JT, Sacchettini JC, etal. An engineered transthyretin monomer that is nonamyloidogenic, unless it is partially denatured. Biochemistry 2001; 40:11442-52.
7. Jiang X, Buxbaum JN, Kelly JW. The V122l cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis. Proc Natl Acad Sci USA 2001; 98:14943-8.
8. Sousa MM, Cardoso I, Fernandes R, Guimaraes A, Saraiva MJ. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of non-fibrillar aggregates. Am J Pathol 2001; 159:1993-2000.
9. Andersson K, Olofsson A, Nielsen EH, Svehag SE, Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem Biophys Res Commun 2002; 294:309-14.
10. Walsh DM, Kiyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002; 30:552-7.
11. Goldsteins G, Andersson K, Olofsson A, Dacklin I, Edvinsson A, Baranov V, et al. Characterization of two highly amyloidogenic mutants of transthyretin. Biochemistry 1997; 36:5346-52.
12. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
13. Olofsson A, Ippel HJ, Baranov V, Horstedt P, Wijmenga S, Lundgren E. Capture of a dimeric intermediate during transthyretin amyloid formation. J Biol Chem 2001; 276:39592-9.
14. Forloni G, Chiesa R, Smiroldo S, Verga L, Salmona M, Tagliavini F, et al. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. Neuroreport 1993; 4:523-6.
15. Bennett MJ, Schlunegger MP, Eisenberg D. 3D domain swapping: a mechanism for oligomer assembly. Protein Sci 1995; 4:2455-68.
16. Richardson JS, Richardson DC. Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation. Proc Natl Acad Sci USA 2002; 99:2754-9.
17. Kelly JW. Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 1996; 6:11-7.
18. Rochet JC, Lansbury PT Jr. Amyloid fibrillogenesis: themes and variations. Curr Opin Struct Biol 2000; 10:60-8.
19. Jarrett JT, Lansbury PT Jr. Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB. Biochemistry 1992; 31:12345-52.
20. Jarrett JT, Berger EP, Lansbury PT Jr. The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 1993; 32:4693-7.
21. Otzen DE, Kristensen O, Oliveberg M. Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. Proc Natl Acad Sci USA 2000; 97:9907-12.
22. Antzutkin ON, Balbach JJ, Leapman RD, Rizzo NW, Reed J, Tycko R. Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of beta-sheets in Alzheimer's beta-amyloid fibrils. Proc Natl Acad Sci USA 2000; 97:13045-50.
23. Lansbury PT Jr, Costa PR, Griffiths JM, Simon EJ, Auger M, Halverson KJ, et al. Structural model for the beta-amyloid fibril based on interstrand alignment of an antiparallel-sheet comprising a C-terminal peptide. Nat Struct Biol 1995; 2:990-8.
24. Ippel JH, Olofsson A, Schleucher J, Lundgren E, Wijmenga SS. Probing solvent accessibility of amyloid fibrils by solution NMR spectroscopy. Proc Natl Acad Sci USA 2002; 99:8648-53.
25. Hoshino M, Katou H, Hagihara Y, Hasegawa K, Naiki H, Goto Y. Mapping the core of the beta(2)-microglobulin amyloid fibril by H/D exchange. Nat Struct Biol 2002; 9:332-6.
26. Inoue S, Kuroiwa M, Saraiva MJ, Guimaraes A, Kisilevsky R. Ultrastructure of familial amyloid polyneuropathy amyloid fibrils: examination with high-resolution electron microscopy. J Struct Biol 1998; 124:1-12.
27. Terzi E, Holzemann G, Seelig J. Self-association of beta-amyloid peptide (1-40) in solution and binding to lipid membranes. J Mol Biol 1995; 252:633-42.
28. Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ. Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways. J Neurosci 2001; 21:7576-86.